MD, H., MR, C., M, M., ZJ, K., S, E., JL, R., . . . H, O. (2024). Utility of cerebrovascular imaging biomarkers to detect cerebral amyloidosis. Alzheimer's & dementia : the journal of the Alzheimer's Association, 20(10), 7220. https://doi.org/10.1002/alz.14207
Chicago Style (17th ed.) CitationMD, Howe, Caruso MR, Manoochehri M, Kunicki ZJ, Emrani S, Rudolph JL, Huey ED, Salloway SP, and Oh H. "Utility of Cerebrovascular Imaging Biomarkers to Detect Cerebral Amyloidosis." Alzheimer's & Dementia : The Journal of the Alzheimer's Association 20, no. 10 (2024): 7220. https://doi.org/10.1002/alz.14207.
MLA (9th ed.) CitationMD, Howe, et al. "Utility of Cerebrovascular Imaging Biomarkers to Detect Cerebral Amyloidosis." Alzheimer's & Dementia : The Journal of the Alzheimer's Association, vol. 20, no. 10, 2024, p. 7220, https://doi.org/10.1002/alz.14207.